Physician profile
Marina Burstein
NPI 1346333440
$4,043.99
in general payments reported to CMS, 2019-2025
25 companies · $1,339 in 2025
The $1,339 reported for 2025 was more than what 98% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $135 · 2021: $549 · 2022: $420 · 2023: $844 · 2024: $582 · 2025: $1,339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,764.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $661.03 | 2021-2025 | Evenity, Otezla |
| Merck Sharp & Dohme LLC | $576.11 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Glaxosmithkline, LLC. | $448.64 | 2019-2025 | Arexvy, Shingrix |
| Janssen Pharmaceuticals, INC | $343.21 | 2021-2023 | Xarelto |
| Novo Nordisk INC | $331.53 | 2023-2025 | Wegovy |
| Pfizer INC. | $273.17 | 2020-2025 | |
| Sanofi Pasteur INC. | $225.26 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $221.86 | 2024-2025 | Dupixent |
| Tris Pharma INC | $154.43 | 2019-2023 | Dyanavel Xr, Quillivant, Quillichew Er |
| Mayne Pharma Commercial LLC | $143.76 | 2025 | |
| Cranial Technologies, INC | $121.76 | 2020-2025 | Doc Band |
| Astrazeneca Pharmaceuticals LP | $116.42 | 2025 | Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.86 | 2022-2023 | Jardiance |
| Hologic Sales and Service, LLC | $54.03 | 2022-2023 | Aptima, Thinprep 2000 Processor |
| Galderma Laboratories, L.P. | $47.74 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $42.45 | 2024 | Ycanth |
| Exact Sciences Corporation | $36.95 | 2023 | Cologuard Collection Kit |
| Phadia US INC. | $36.88 | 2024-2025 | Immunocap |
| Bayer Healthcare Pharmaceuticals INC. | $24.80 | 2019 | |
| Lilly USA, LLC | $24.45 | 2023 | Taltz |
| Idorsia Pharmaceuticals US INC | $19.43 | 2023 | Quviviq |
| Cognoa, INC. | $19.25 | 2021 | |
| Eisai INC. | $19.23 | 2021 | |
| Alk-Abello, INC | $15.98 | 2023 | Ragwitek, Odactra, Grastek |
| Seqirus USA INC | $14.76 | 2025 | Flucelvax, Fluad |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marina Burstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.